ES2178302T3 - Inhibidores de beta-lactamasa a base de fosf(on)ato de acilo. - Google Patents

Inhibidores de beta-lactamasa a base de fosf(on)ato de acilo.

Info

Publication number
ES2178302T3
ES2178302T3 ES98965488T ES98965488T ES2178302T3 ES 2178302 T3 ES2178302 T3 ES 2178302T3 ES 98965488 T ES98965488 T ES 98965488T ES 98965488 T ES98965488 T ES 98965488T ES 2178302 T3 ES2178302 T3 ES 2178302T3
Authority
ES
Spain
Prior art keywords
beta
lactamase inhibitors
inhibitors
fosf
acilo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98965488T
Other languages
English (en)
Inventor
Jeffrey M Besterman
Jubrail Rahil
Rex Pratt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Methylgene Inc
Wesleyan University
Original Assignee
Methylgene Inc
Wesleyan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Methylgene Inc, Wesleyan University filed Critical Methylgene Inc
Application granted granted Critical
Publication of ES2178302T3 publication Critical patent/ES2178302T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/409—Compounds containing the structure P(=X)-X-acyl, P(=X) -X-heteroatom, P(=X)-X-CN (X = O, S, Se)
    • C07F9/4093—Compounds containing the structure P(=X)-X-C(=X)- (X = O, S, Se)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/095—Compounds containing the structure P(=O)-O-acyl, P(=O)-O-heteroatom, P(=O)-O-CN
    • C07F9/096—Compounds containing the structure P(=O)-O-C(=X)- (X = O, S, Se)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/098—Esters of polyphosphoric acids or anhydrides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65742—Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574—Esters of oxyacids of phosphorus
    • C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Un inhibidor de 13-lactamasa de fórmula I: **(Fórmula)** o una de sus sales; en la que X es un radical alquilo, alquenilo, alquinilo, arilo, arilalquilo o heterocíclico; Y es Z u OZ; y Z es un radical alquilo, alquenilo, alquinilo, arilo, arilalquilo, acilo, heterocíclico, fosfonilo o X; con la condición, sin embargo, de que cuando Y es Z, entonces Z no es fosfonilo; y con la condición adicional de que cuando Y es OZ y Z es fenilo, entonces X no es metilo o fenilo; cuando Y es OZ y Z es alquilo o adenosilo, entonces X no es un aminoácido; cuando Y es Z y Z es metilo, entonces X no es metilo; cuando Y es OZ y Z es acetilfosfonilo, entonces X no es metilo; y cuando Y es OZ y Z es benzoílo, entonces X no es fenilo.
ES98965488T 1997-12-24 1998-12-23 Inhibidores de beta-lactamasa a base de fosf(on)ato de acilo. Expired - Lifetime ES2178302T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6883797P 1997-12-24 1997-12-24

Publications (1)

Publication Number Publication Date
ES2178302T3 true ES2178302T3 (es) 2002-12-16

Family

ID=22085029

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98965488T Expired - Lifetime ES2178302T3 (es) 1997-12-24 1998-12-23 Inhibidores de beta-lactamasa a base de fosf(on)ato de acilo.

Country Status (10)

Country Link
US (1) US6608046B1 (es)
EP (1) EP1042334B1 (es)
JP (1) JP2002503643A (es)
KR (1) KR100591572B1 (es)
AT (1) ATE217875T1 (es)
AU (1) AU755799B2 (es)
CA (1) CA2315821A1 (es)
DE (1) DE69805548T2 (es)
ES (1) ES2178302T3 (es)
WO (1) WO1999033850A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599889B2 (en) * 1997-12-24 2003-07-29 Methylgere, Inc. Acyl phosphonate inhibitors of β-lactamases
US6921756B2 (en) 1999-07-06 2005-07-26 Methylgene, Inc. Inhibitors of β-lactamase
US6884791B2 (en) 1999-07-06 2005-04-26 Methylgene, Inc. Inhibitors of β-lactamase
AU770599B2 (en) 1999-07-06 2004-02-26 Methylgene Inc. Sulfonamidomethyl phosphonate inhibitors of beta-lactamase
WO2008073142A2 (en) * 2006-05-22 2008-06-19 Merck & Co., Inc. Novel inhibitors of beta-lactamase
JP2009538302A (ja) * 2006-05-22 2009-11-05 メチルジーン・インコーポレイテッド 新規なベータ−ラクタマーゼのスルホンアミドメチルホスホネート阻害剤
WO2009114921A1 (en) * 2008-03-17 2009-09-24 Dmitrienko Gary I INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES
WO2013053953A1 (en) * 2011-10-14 2013-04-18 Université de Liège Method for measuring beta-lactam antibiotics
CN104159587A (zh) * 2012-01-06 2014-11-19 南佛罗里达大学 组合物、使用方法、以及治疗方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8603812D0 (sv) * 1986-09-12 1986-09-12 Draco Ab Administration of liposomes to mammals
ES2082971T3 (es) * 1990-03-14 1996-04-01 Univ Toronto Esteres de fosfato de acilo y modificacion de proteinas con los mismos.
US5250665A (en) * 1991-05-31 1993-10-05 The University Of Toronto Innovations Foundation Specifically β-β cross-linked hemoglobins and method of preparation

Also Published As

Publication number Publication date
EP1042334B1 (en) 2002-05-22
KR100591572B1 (ko) 2006-06-20
WO1999033850A8 (en) 1999-09-10
AU755799B2 (en) 2002-12-19
CA2315821A1 (en) 1999-07-08
DE69805548T2 (de) 2003-01-09
KR20010033621A (ko) 2001-04-25
DE69805548D1 (en) 2002-06-27
US6608046B1 (en) 2003-08-19
EP1042334A1 (en) 2000-10-11
AU2094599A (en) 1999-07-19
ATE217875T1 (de) 2002-06-15
JP2002503643A (ja) 2002-02-05
WO1999033850A1 (en) 1999-07-08

Similar Documents

Publication Publication Date Title
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
PT904274E (pt) Inibidores da farnesil transferase
PT1193270E (pt) Pirrolobenzodiazepinas
BG103485A (en) Ketobanzamides as calpain inhibitors
ATE225772T1 (de) Thrombin-inhibitoren
AU2733997A (en) N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
DE59202238D1 (de) Hilfsmittel für laparoskopische Operationen.
ES2149883T3 (es) Sintesis quimica de taxol y de derivados de taxol.
TR199800773T2 (xx) Trombin inhibit�rleri.
ZA941968B (en) Process for the purification of taxoids
MX9605206A (es) 1alfa,26-dihidroxi-d-homo-vitamina d3.
AU674378B2 (en) Use of 2-amino-6-A-propylamino-4,5,6, 7-tetrahydrobenzothiazole (pramipexol) as an anti-depressantdrug
IL127574A0 (en) Inhibitors of prenyl transferases
TW223630B (en) Retroviral protease inhibitors
PT989972E (pt) Composicoes farmaceuticas com prostaglandinas
ATE311397T1 (de) Sulfonamidomethyl phosphonat beta-lactamase inhibitoren
DE69805548D1 (en) Acylphosph(on)at beta-lactamase inhibitoren
DE69804125D1 (de) Verwendung von immunomodulatoren
MX9801190A (es) Inhibidores de prolil endopeptidasa.
DE69515901D1 (de) Szintillation-annäherungstest für n-acetylgalactosaminyl transferase-aktivität
TR199701298T1 (xx) Tetralinler.
ATE231510T1 (de) Penamsulfone als beta-laktamase inhibitoren
ZA966885B (en) Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors.
MX9801792A (es) Inhibidores cicloantihelminticos.